Texas Instruments: Capacity investment meets a measured demand recovery

Transcript intelligence

What changed

Relative to the prior analysis, management's tone became more confident, guidance remained maintained, and the discussion emphasized sequential improvement, higher 300-mm utilization, internal embedded-processing production, and design-in opportunities. The key unresolved issues shifted toward the sources of Q3 growth, geopolitics, CHIPS Act credit timing, and capex and depreciation scenarios.

Guidance delta

Management maintained guidance and indicated modest Q3 revenue and EPS growth, signaling a measured seasonal recovery rather than a broad-based rebound.

Key takeaways

• Q2 revenue rose sequentially to $3.8 billion, while remaining down year over year; personal electronics and enterprise systems grew as analog and embedded processing declined.
• Management highlighted higher 300-mm wafer loadings, lower unit costs, and margin expansion from improved capacity utilization.
• The Q3 outlook calls for modest revenue and EPS growth, with recovery dependent on end-market demand and utilization.
• Internal production of embedded processing at the Lehi fab could support future margins.
• CHIPS Act tax credits and continued capacity expansion remain important to the long-term investment case.

Management priorities

• Continue building 300-mm capacity in Texas and Utah.
• Increase internal embedded-processing production at the Lehi fab.
• Pursue automotive radar, EV-charger, and MCU catalog design-ins.
• Use the ti.com digital channel to improve customer engagement.
• Maintain the long-term capacity-investment program while evaluating capex scenarios.